Javascript must be enabled to continue!
Métis Research Ethics
View through CrossRef
The Métis author shares her experiences navigating relationships with the Manitoba Métis Federation (MMF) across her research studies on Métis spirituality, especially relationships with traditional Indigenous ceremonies, underscoring ethical considerations. Recent efforts by the MMF to assert sovereignty as a safeguard against Métis identity fraud, and subsequent impacts upon Métis research and scholarship are also discussed. An argument is put forward that the academic freedom of Métis citizen scholars need not be pitted against Métis government efforts at sovereignty–rather than viewing these as mutually exclusive, they can co-exist to promote ethical Métis scholarship and self-determination.
Title: Métis Research Ethics
Description:
The Métis author shares her experiences navigating relationships with the Manitoba Métis Federation (MMF) across her research studies on Métis spirituality, especially relationships with traditional Indigenous ceremonies, underscoring ethical considerations.
Recent efforts by the MMF to assert sovereignty as a safeguard against Métis identity fraud, and subsequent impacts upon Métis research and scholarship are also discussed.
An argument is put forward that the academic freedom of Métis citizen scholars need not be pitted against Métis government efforts at sovereignty–rather than viewing these as mutually exclusive, they can co-exist to promote ethical Métis scholarship and self-determination.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Researching Métis Spirituality
Researching Métis Spirituality
Dr. Chantal Fiola has been studying Métis spirituality, especially relationships with traditional ceremonies, for more than 15 years. In the pages to follow, she outlines her docto...
Archaeology of the Métis
Archaeology of the Métis
AbstractThis article reviews the history of Métis archaeological research in Canada. The Métis of Canada arose as a distinct Indigenous identity in the postcontact period and provi...
Métis Coming Together
Métis Coming Together
Métis Coming Together invites readers to witness the knowledge exchanges that occur in community. Diverse perspectives from Métis across the homeland help us convene a dynamic and ...
Towards AI ethics’ institutionalization: knowledge bridges from business ethics to advance organizational AI ethics
Towards AI ethics’ institutionalization: knowledge bridges from business ethics to advance organizational AI ethics
AbstractThis paper proposes to generate awareness for developing Artificial intelligence (AI) ethics by transferring knowledge from other fields of applied ethics, particularly fro...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...

